nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—CYP2C8—Paclitaxel—ovarian cancer	0.0723	0.302	CbGbCtD
Repaglinide—CYP3A4—Topotecan—ovarian cancer	0.0592	0.247	CbGbCtD
Repaglinide—CYP3A4—Vinorelbine—ovarian cancer	0.0417	0.174	CbGbCtD
Repaglinide—CYP3A4—Paclitaxel—ovarian cancer	0.0293	0.122	CbGbCtD
Repaglinide—PPARG—Irinotecan—Topotecan—ovarian cancer	0.0222	1	CbGdCrCtD
Repaglinide—CYP3A4—Docetaxel—ovarian cancer	0.0212	0.0885	CbGbCtD
Repaglinide—CYP3A4—Doxorubicin—ovarian cancer	0.0158	0.0659	CbGbCtD
Repaglinide—PPARG—embryo—ovarian cancer	0.00241	0.0743	CbGeAlD
Repaglinide—ABCC8—endometrium—ovarian cancer	0.00231	0.0712	CbGeAlD
Repaglinide—Hyperglycaemia—Paclitaxel—ovarian cancer	0.00218	0.00398	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00217	0.00397	CcSEcCtD
Repaglinide—Hypertension—Vinorelbine—ovarian cancer	0.00216	0.00394	CcSEcCtD
Repaglinide—Paraesthesia—Topotecan—ovarian cancer	0.00214	0.00391	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.00213	0.0039	CcSEcCtD
Repaglinide—Urticaria—Chlorambucil—ovarian cancer	0.00213	0.00389	CcSEcCtD
Repaglinide—Chest pain—Vinorelbine—ovarian cancer	0.00213	0.00389	CcSEcCtD
Repaglinide—Arthralgia—Vinorelbine—ovarian cancer	0.00213	0.00389	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00213	0.00389	CcSEcCtD
Repaglinide—Acute coronary syndrome—Paclitaxel—ovarian cancer	0.00212	0.00387	CcSEcCtD
Repaglinide—Abdominal pain—Chlorambucil—ovarian cancer	0.00212	0.00387	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00212	0.00386	CcSEcCtD
Repaglinide—Myocardial infarction—Paclitaxel—ovarian cancer	0.00211	0.00385	CcSEcCtD
Repaglinide—Dyspepsia—Topotecan—ovarian cancer	0.0021	0.00383	CcSEcCtD
Repaglinide—Paraesthesia—Melphalan—ovarian cancer	0.0021	0.00383	CcSEcCtD
Repaglinide—Urinary tract infection—Paclitaxel—ovarian cancer	0.00209	0.00382	CcSEcCtD
Repaglinide—KCNJ11—female reproductive system—ovarian cancer	0.00208	0.064	CbGeAlD
Repaglinide—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00206	0.00376	CcSEcCtD
Repaglinide—Dyspepsia—Melphalan—ovarian cancer	0.00206	0.00375	CcSEcCtD
Repaglinide—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00204	0.00373	CcSEcCtD
Repaglinide—Constipation—Topotecan—ovarian cancer	0.00204	0.00372	CcSEcCtD
Repaglinide—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.00204	0.00372	CcSEcCtD
Repaglinide—Sinusitis—Paclitaxel—ovarian cancer	0.00202	0.00369	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00202	0.00368	CcSEcCtD
Repaglinide—Thrombocytopenia—Vinorelbine—ovarian cancer	0.002	0.00365	CcSEcCtD
Repaglinide—Angina pectoris—Docetaxel—ovarian cancer	0.00199	0.00364	CcSEcCtD
Repaglinide—Skin disorder—Vinorelbine—ovarian cancer	0.00198	0.00362	CcSEcCtD
Repaglinide—Hypersensitivity—Chlorambucil—ovarian cancer	0.00198	0.0036	CcSEcCtD
Repaglinide—PPARG—epithelium—ovarian cancer	0.00197	0.0606	CbGeAlD
Repaglinide—Gastrointestinal pain—Topotecan—ovarian cancer	0.00195	0.00356	CcSEcCtD
Repaglinide—Rhinitis—Paclitaxel—ovarian cancer	0.00194	0.00354	CcSEcCtD
Repaglinide—Oedema peripheral—Paclitaxel—ovarian cancer	0.0019	0.00347	CcSEcCtD
Repaglinide—Pruritus—Chlorambucil—ovarian cancer	0.0019	0.00346	CcSEcCtD
Repaglinide—Urticaria—Topotecan—ovarian cancer	0.0019	0.00346	CcSEcCtD
Repaglinide—KCNJ11—female gonad—ovarian cancer	0.00189	0.0583	CbGeAlD
Repaglinide—Abdominal pain—Topotecan—ovarian cancer	0.00189	0.00344	CcSEcCtD
Repaglinide—Visual impairment—Paclitaxel—ovarian cancer	0.00186	0.0034	CcSEcCtD
Repaglinide—PPARG—decidua—ovarian cancer	0.00186	0.0572	CbGeAlD
Repaglinide—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00186	0.00339	CcSEcCtD
Repaglinide—Urticaria—Melphalan—ovarian cancer	0.00186	0.00339	CcSEcCtD
Repaglinide—Diarrhoea—Chlorambucil—ovarian cancer	0.00183	0.00335	CcSEcCtD
Repaglinide—Paraesthesia—Vinorelbine—ovarian cancer	0.00183	0.00335	CcSEcCtD
Repaglinide—Hepatic function abnormal—Epirubicin—ovarian cancer	0.00183	0.00334	CcSEcCtD
Repaglinide—Erythema multiforme—Paclitaxel—ovarian cancer	0.00183	0.00334	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00181	0.0033	CcSEcCtD
Repaglinide—Eye disorder—Paclitaxel—ovarian cancer	0.00181	0.0033	CcSEcCtD
Repaglinide—Acute coronary syndrome—Docetaxel—ovarian cancer	0.0018	0.00328	CcSEcCtD
Repaglinide—Cardiac disorder—Paclitaxel—ovarian cancer	0.00179	0.00327	CcSEcCtD
Repaglinide—Myocardial infarction—Docetaxel—ovarian cancer	0.00179	0.00326	CcSEcCtD
Repaglinide—Jaundice—Docetaxel—ovarian cancer	0.00178	0.00325	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00176	0.00322	CcSEcCtD
Repaglinide—Cardiac failure congestive—Epirubicin—ovarian cancer	0.00176	0.00321	CcSEcCtD
Repaglinide—Hypersensitivity—Topotecan—ovarian cancer	0.00176	0.00321	CcSEcCtD
Repaglinide—Constipation—Vinorelbine—ovarian cancer	0.00175	0.00319	CcSEcCtD
Repaglinide—Immune system disorder—Paclitaxel—ovarian cancer	0.00175	0.00319	CcSEcCtD
Repaglinide—Arrhythmia—Paclitaxel—ovarian cancer	0.00173	0.00315	CcSEcCtD
Repaglinide—Hepatobiliary disease—Docetaxel—ovarian cancer	0.00173	0.00315	CcSEcCtD
Repaglinide—Hypersensitivity—Melphalan—ovarian cancer	0.00172	0.00314	CcSEcCtD
Repaglinide—Alopecia—Paclitaxel—ovarian cancer	0.00171	0.00312	CcSEcCtD
Repaglinide—Vomiting—Chlorambucil—ovarian cancer	0.0017	0.00311	CcSEcCtD
Repaglinide—SLCO1B1—female reproductive system—ovarian cancer	0.0017	0.0522	CbGeAlD
Repaglinide—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.00169	0.00309	CcSEcCtD
Repaglinide—Pruritus—Topotecan—ovarian cancer	0.00169	0.00308	CcSEcCtD
Repaglinide—Erythema—Paclitaxel—ovarian cancer	0.00168	0.00307	CcSEcCtD
Repaglinide—Malnutrition—Paclitaxel—ovarian cancer	0.00168	0.00307	CcSEcCtD
Repaglinide—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00167	0.00305	CcSEcCtD
Repaglinide—Pruritus—Melphalan—ovarian cancer	0.00165	0.00302	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00165	0.00301	CcSEcCtD
Repaglinide—Rhinitis—Docetaxel—ovarian cancer	0.00164	0.003	CcSEcCtD
Repaglinide—Hepatitis—Docetaxel—ovarian cancer	0.00164	0.00299	CcSEcCtD
Repaglinide—Hypoglycaemia—Epirubicin—ovarian cancer	0.00164	0.00299	CcSEcCtD
Repaglinide—Diarrhoea—Topotecan—ovarian cancer	0.00163	0.00298	CcSEcCtD
Repaglinide—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.00163	0.00297	CcSEcCtD
Repaglinide—Back pain—Paclitaxel—ovarian cancer	0.00163	0.00297	CcSEcCtD
Repaglinide—PPARG—uterus—ovarian cancer	0.00163	0.0501	CbGeAlD
Repaglinide—Urticaria—Vinorelbine—ovarian cancer	0.00162	0.00296	CcSEcCtD
Repaglinide—Abdominal pain—Vinorelbine—ovarian cancer	0.00161	0.00295	CcSEcCtD
Repaglinide—Oedema peripheral—Docetaxel—ovarian cancer	0.00161	0.00295	CcSEcCtD
Repaglinide—Diarrhoea—Melphalan—ovarian cancer	0.0016	0.00292	CcSEcCtD
Repaglinide—Nausea—Chlorambucil—ovarian cancer	0.00159	0.00291	CcSEcCtD
Repaglinide—Visual impairment—Docetaxel—ovarian cancer	0.00158	0.00288	CcSEcCtD
Repaglinide—Erythema multiforme—Docetaxel—ovarian cancer	0.00155	0.00283	CcSEcCtD
Repaglinide—ABCC8—testis—ovarian cancer	0.00155	0.0476	CbGeAlD
Repaglinide—Eye disorder—Docetaxel—ovarian cancer	0.00153	0.00279	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00153	0.00279	CcSEcCtD
Repaglinide—Cardiac disorder—Docetaxel—ovarian cancer	0.00152	0.00277	CcSEcCtD
Repaglinide—Vomiting—Topotecan—ovarian cancer	0.00152	0.00277	CcSEcCtD
Repaglinide—Hypoglycaemia—Doxorubicin—ovarian cancer	0.00151	0.00276	CcSEcCtD
Repaglinide—Leukopenia—Paclitaxel—ovarian cancer	0.00151	0.00275	CcSEcCtD
Repaglinide—Rash—Topotecan—ovarian cancer	0.0015	0.00275	CcSEcCtD
Repaglinide—Hypersensitivity—Vinorelbine—ovarian cancer	0.0015	0.00274	CcSEcCtD
Repaglinide—Dermatitis—Topotecan—ovarian cancer	0.0015	0.00274	CcSEcCtD
Repaglinide—Headache—Topotecan—ovarian cancer	0.0015	0.00273	CcSEcCtD
Repaglinide—Palpitations—Paclitaxel—ovarian cancer	0.00149	0.00271	CcSEcCtD
Repaglinide—Vomiting—Melphalan—ovarian cancer	0.00149	0.00271	CcSEcCtD
Repaglinide—Immune system disorder—Docetaxel—ovarian cancer	0.00148	0.0027	CcSEcCtD
Repaglinide—Rash—Melphalan—ovarian cancer	0.00147	0.00269	CcSEcCtD
Repaglinide—Dermatitis—Melphalan—ovarian cancer	0.00147	0.00269	CcSEcCtD
Repaglinide—Arrhythmia—Docetaxel—ovarian cancer	0.00146	0.00267	CcSEcCtD
Repaglinide—PPARG—female reproductive system—ovarian cancer	0.00146	0.045	CbGeAlD
Repaglinide—Hypertension—Paclitaxel—ovarian cancer	0.00145	0.00265	CcSEcCtD
Repaglinide—Alopecia—Docetaxel—ovarian cancer	0.00145	0.00264	CcSEcCtD
Repaglinide—Pruritus—Vinorelbine—ovarian cancer	0.00144	0.00264	CcSEcCtD
Repaglinide—Arthralgia—Paclitaxel—ovarian cancer	0.00143	0.00261	CcSEcCtD
Repaglinide—Chest pain—Paclitaxel—ovarian cancer	0.00143	0.00261	CcSEcCtD
Repaglinide—Erythema—Docetaxel—ovarian cancer	0.00143	0.0026	CcSEcCtD
Repaglinide—Malnutrition—Docetaxel—ovarian cancer	0.00143	0.0026	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00142	0.0026	CcSEcCtD
Repaglinide—Nausea—Topotecan—ovarian cancer	0.00142	0.00259	CcSEcCtD
Repaglinide—Diarrhoea—Vinorelbine—ovarian cancer	0.0014	0.00255	CcSEcCtD
Repaglinide—Nausea—Melphalan—ovarian cancer	0.00139	0.00253	CcSEcCtD
Repaglinide—PPARG—bone marrow—ovarian cancer	0.00138	0.0425	CbGeAlD
Repaglinide—Back pain—Docetaxel—ovarian cancer	0.00138	0.00252	CcSEcCtD
Repaglinide—Oedema—Paclitaxel—ovarian cancer	0.00137	0.00251	CcSEcCtD
Repaglinide—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00137	0.00251	CcSEcCtD
Repaglinide—Pancreatitis—Epirubicin—ovarian cancer	0.00135	0.00247	CcSEcCtD
Repaglinide—Angina pectoris—Epirubicin—ovarian cancer	0.00134	0.00245	CcSEcCtD
Repaglinide—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00134	0.00245	CcSEcCtD
Repaglinide—Skin disorder—Paclitaxel—ovarian cancer	0.00133	0.00243	CcSEcCtD
Repaglinide—PPARG—female gonad—ovarian cancer	0.00133	0.041	CbGeAlD
Repaglinide—Bronchitis—Epirubicin—ovarian cancer	0.00133	0.00242	CcSEcCtD
Repaglinide—PPARG—vagina—ovarian cancer	0.00132	0.0407	CbGeAlD
Repaglinide—Vomiting—Vinorelbine—ovarian cancer	0.0013	0.00237	CcSEcCtD
Repaglinide—Rash—Vinorelbine—ovarian cancer	0.00129	0.00235	CcSEcCtD
Repaglinide—Dermatitis—Vinorelbine—ovarian cancer	0.00129	0.00235	CcSEcCtD
Repaglinide—Headache—Vinorelbine—ovarian cancer	0.00128	0.00233	CcSEcCtD
Repaglinide—Leukopenia—Docetaxel—ovarian cancer	0.00128	0.00233	CcSEcCtD
Repaglinide—Palpitations—Docetaxel—ovarian cancer	0.00126	0.0023	CcSEcCtD
Repaglinide—Pancreatitis—Doxorubicin—ovarian cancer	0.00125	0.00229	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00125	0.00228	CcSEcCtD
Repaglinide—Hyperglycaemia—Epirubicin—ovarian cancer	0.00125	0.00227	CcSEcCtD
Repaglinide—Angina pectoris—Doxorubicin—ovarian cancer	0.00124	0.00227	CcSEcCtD
Repaglinide—Paraesthesia—Paclitaxel—ovarian cancer	0.00123	0.00225	CcSEcCtD
Repaglinide—Hypertension—Docetaxel—ovarian cancer	0.00123	0.00225	CcSEcCtD
Repaglinide—Bronchitis—Doxorubicin—ovarian cancer	0.00123	0.00224	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00122	0.00223	CcSEcCtD
Repaglinide—KCNJ11—lymph node—ovarian cancer	0.00122	0.0375	CbGeAlD
Repaglinide—Arthralgia—Docetaxel—ovarian cancer	0.00121	0.00222	CcSEcCtD
Repaglinide—Chest pain—Docetaxel—ovarian cancer	0.00121	0.00222	CcSEcCtD
Repaglinide—Nausea—Vinorelbine—ovarian cancer	0.00121	0.00221	CcSEcCtD
Repaglinide—Dyspepsia—Paclitaxel—ovarian cancer	0.00121	0.00221	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00121	0.0022	CcSEcCtD
Repaglinide—Jaundice—Epirubicin—ovarian cancer	0.0012	0.00219	CcSEcCtD
Repaglinide—Urinary tract infection—Epirubicin—ovarian cancer	0.0012	0.00218	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00119	0.00216	CcSEcCtD
Repaglinide—PPARG—testis—ovarian cancer	0.00118	0.0363	CbGeAlD
Repaglinide—Constipation—Paclitaxel—ovarian cancer	0.00117	0.00214	CcSEcCtD
Repaglinide—Hepatobiliary disease—Epirubicin—ovarian cancer	0.00116	0.00212	CcSEcCtD
Repaglinide—CYP2C8—endometrium—ovarian cancer	0.00116	0.0358	CbGeAlD
Repaglinide—Anaphylactic shock—Docetaxel—ovarian cancer	0.00116	0.00212	CcSEcCtD
Repaglinide—Oedema—Docetaxel—ovarian cancer	0.00116	0.00212	CcSEcCtD
Repaglinide—Sinusitis—Epirubicin—ovarian cancer	0.00115	0.00211	CcSEcCtD
Repaglinide—Hyperglycaemia—Doxorubicin—ovarian cancer	0.00115	0.0021	CcSEcCtD
Repaglinide—Thrombocytopenia—Docetaxel—ovarian cancer	0.00114	0.00208	CcSEcCtD
Repaglinide—Skin disorder—Docetaxel—ovarian cancer	0.00113	0.00206	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00113	0.00206	CcSEcCtD
Repaglinide—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00112	0.00205	CcSEcCtD
Repaglinide—Jaundice—Doxorubicin—ovarian cancer	0.00111	0.00203	CcSEcCtD
Repaglinide—Rhinitis—Epirubicin—ovarian cancer	0.00111	0.00202	CcSEcCtD
Repaglinide—ALB—testis—ovarian cancer	0.00111	0.0341	CbGeAlD
Repaglinide—Urinary tract infection—Doxorubicin—ovarian cancer	0.00111	0.00202	CcSEcCtD
Repaglinide—Hepatitis—Epirubicin—ovarian cancer	0.00111	0.00202	CcSEcCtD
Repaglinide—Urticaria—Paclitaxel—ovarian cancer	0.00109	0.00199	CcSEcCtD
Repaglinide—Oedema peripheral—Epirubicin—ovarian cancer	0.00109	0.00199	CcSEcCtD
Repaglinide—Abdominal pain—Paclitaxel—ovarian cancer	0.00109	0.00198	CcSEcCtD
Repaglinide—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.00108	0.00197	CcSEcCtD
Repaglinide—Sinusitis—Doxorubicin—ovarian cancer	0.00107	0.00195	CcSEcCtD
Repaglinide—Visual impairment—Epirubicin—ovarian cancer	0.00106	0.00194	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00106	0.00194	CcSEcCtD
Repaglinide—Paraesthesia—Docetaxel—ovarian cancer	0.00105	0.00191	CcSEcCtD
Repaglinide—Erythema multiforme—Epirubicin—ovarian cancer	0.00104	0.00191	CcSEcCtD
Repaglinide—Eye disorder—Epirubicin—ovarian cancer	0.00103	0.00188	CcSEcCtD
Repaglinide—Cardiac disorder—Epirubicin—ovarian cancer	0.00103	0.00187	CcSEcCtD
Repaglinide—Rhinitis—Doxorubicin—ovarian cancer	0.00103	0.00187	CcSEcCtD
Repaglinide—Dyspepsia—Docetaxel—ovarian cancer	0.00102	0.00187	CcSEcCtD
Repaglinide—Hepatitis—Doxorubicin—ovarian cancer	0.00102	0.00187	CcSEcCtD
Repaglinide—Hypersensitivity—Paclitaxel—ovarian cancer	0.00101	0.00185	CcSEcCtD
Repaglinide—Oedema peripheral—Doxorubicin—ovarian cancer	0.00101	0.00184	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.001	0.00183	CcSEcCtD
Repaglinide—Immune system disorder—Epirubicin—ovarian cancer	0.000998	0.00182	CcSEcCtD
Repaglinide—Constipation—Docetaxel—ovarian cancer	0.000995	0.00182	CcSEcCtD
Repaglinide—Arrhythmia—Epirubicin—ovarian cancer	0.000987	0.0018	CcSEcCtD
Repaglinide—Visual impairment—Doxorubicin—ovarian cancer	0.000985	0.0018	CcSEcCtD
Repaglinide—Alopecia—Epirubicin—ovarian cancer	0.000976	0.00178	CcSEcCtD
Repaglinide—Pruritus—Paclitaxel—ovarian cancer	0.000972	0.00177	CcSEcCtD
Repaglinide—Erythema multiforme—Doxorubicin—ovarian cancer	0.000967	0.00176	CcSEcCtD
Repaglinide—CYP2C8—female reproductive system—ovarian cancer	0.000964	0.0297	CbGeAlD
Repaglinide—Malnutrition—Epirubicin—ovarian cancer	0.000962	0.00176	CcSEcCtD
Repaglinide—Erythema—Epirubicin—ovarian cancer	0.000962	0.00176	CcSEcCtD
Repaglinide—Eye disorder—Doxorubicin—ovarian cancer	0.000956	0.00174	CcSEcCtD
Repaglinide—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000952	0.00174	CcSEcCtD
Repaglinide—Cardiac disorder—Doxorubicin—ovarian cancer	0.000949	0.00173	CcSEcCtD
Repaglinide—Diarrhoea—Paclitaxel—ovarian cancer	0.00094	0.00171	CcSEcCtD
Repaglinide—Back pain—Epirubicin—ovarian cancer	0.00093	0.0017	CcSEcCtD
Repaglinide—Immune system disorder—Doxorubicin—ovarian cancer	0.000924	0.00169	CcSEcCtD
Repaglinide—Abdominal pain—Docetaxel—ovarian cancer	0.00092	0.00168	CcSEcCtD
Repaglinide—Arrhythmia—Doxorubicin—ovarian cancer	0.000913	0.00167	CcSEcCtD
Repaglinide—Alopecia—Doxorubicin—ovarian cancer	0.000903	0.00165	CcSEcCtD
Repaglinide—Erythema—Doxorubicin—ovarian cancer	0.00089	0.00162	CcSEcCtD
Repaglinide—Malnutrition—Doxorubicin—ovarian cancer	0.00089	0.00162	CcSEcCtD
Repaglinide—Vomiting—Paclitaxel—ovarian cancer	0.000873	0.00159	CcSEcCtD
Repaglinide—CYP2C8—vagina—ovarian cancer	0.000872	0.0268	CbGeAlD
Repaglinide—Rash—Paclitaxel—ovarian cancer	0.000866	0.00158	CcSEcCtD
Repaglinide—Dermatitis—Paclitaxel—ovarian cancer	0.000865	0.00158	CcSEcCtD
Repaglinide—Leukopenia—Epirubicin—ovarian cancer	0.000861	0.00157	CcSEcCtD
Repaglinide—Back pain—Doxorubicin—ovarian cancer	0.000861	0.00157	CcSEcCtD
Repaglinide—Headache—Paclitaxel—ovarian cancer	0.00086	0.00157	CcSEcCtD
Repaglinide—Hypersensitivity—Docetaxel—ovarian cancer	0.000858	0.00156	CcSEcCtD
Repaglinide—PPARG—lymph node—ovarian cancer	0.000856	0.0263	CbGeAlD
Repaglinide—Palpitations—Epirubicin—ovarian cancer	0.00085	0.00155	CcSEcCtD
Repaglinide—Hypertension—Epirubicin—ovarian cancer	0.00083	0.00152	CcSEcCtD
Repaglinide—Pruritus—Docetaxel—ovarian cancer	0.000823	0.0015	CcSEcCtD
Repaglinide—Arthralgia—Epirubicin—ovarian cancer	0.000819	0.00149	CcSEcCtD
Repaglinide—Chest pain—Epirubicin—ovarian cancer	0.000819	0.00149	CcSEcCtD
Repaglinide—Nausea—Paclitaxel—ovarian cancer	0.000816	0.00149	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000813	0.00148	CcSEcCtD
Repaglinide—ALB—lymph node—ovarian cancer	0.000803	0.0247	CbGeAlD
Repaglinide—Leukopenia—Doxorubicin—ovarian cancer	0.000797	0.00145	CcSEcCtD
Repaglinide—Diarrhoea—Docetaxel—ovarian cancer	0.000796	0.00145	CcSEcCtD
Repaglinide—Palpitations—Doxorubicin—ovarian cancer	0.000787	0.00144	CcSEcCtD
Repaglinide—Oedema—Epirubicin—ovarian cancer	0.000785	0.00143	CcSEcCtD
Repaglinide—Anaphylactic shock—Epirubicin—ovarian cancer	0.000785	0.00143	CcSEcCtD
Repaglinide—CYP2C8—testis—ovarian cancer	0.000778	0.024	CbGeAlD
Repaglinide—Thrombocytopenia—Epirubicin—ovarian cancer	0.000769	0.0014	CcSEcCtD
Repaglinide—Hypertension—Doxorubicin—ovarian cancer	0.000768	0.0014	CcSEcCtD
Repaglinide—Skin disorder—Epirubicin—ovarian cancer	0.000763	0.00139	CcSEcCtD
Repaglinide—Arthralgia—Doxorubicin—ovarian cancer	0.000758	0.00138	CcSEcCtD
Repaglinide—Chest pain—Doxorubicin—ovarian cancer	0.000758	0.00138	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000753	0.00137	CcSEcCtD
Repaglinide—Vomiting—Docetaxel—ovarian cancer	0.00074	0.00135	CcSEcCtD
Repaglinide—Rash—Docetaxel—ovarian cancer	0.000734	0.00134	CcSEcCtD
Repaglinide—Dermatitis—Docetaxel—ovarian cancer	0.000733	0.00134	CcSEcCtD
Repaglinide—Headache—Docetaxel—ovarian cancer	0.000729	0.00133	CcSEcCtD
Repaglinide—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000726	0.00133	CcSEcCtD
Repaglinide—Oedema—Doxorubicin—ovarian cancer	0.000726	0.00133	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000715	0.00131	CcSEcCtD
Repaglinide—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000711	0.0013	CcSEcCtD
Repaglinide—Skin disorder—Doxorubicin—ovarian cancer	0.000706	0.00129	CcSEcCtD
Repaglinide—Paraesthesia—Epirubicin—ovarian cancer	0.000705	0.00129	CcSEcCtD
Repaglinide—Nausea—Docetaxel—ovarian cancer	0.000691	0.00126	CcSEcCtD
Repaglinide—Dyspepsia—Epirubicin—ovarian cancer	0.000691	0.00126	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000678	0.00124	CcSEcCtD
Repaglinide—Constipation—Epirubicin—ovarian cancer	0.000671	0.00123	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000662	0.00121	CcSEcCtD
Repaglinide—CYP3A4—female reproductive system—ovarian cancer	0.000653	0.0201	CbGeAlD
Repaglinide—Paraesthesia—Doxorubicin—ovarian cancer	0.000652	0.00119	CcSEcCtD
Repaglinide—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000642	0.00117	CcSEcCtD
Repaglinide—Dyspepsia—Doxorubicin—ovarian cancer	0.000639	0.00117	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000627	0.00114	CcSEcCtD
Repaglinide—Urticaria—Epirubicin—ovarian cancer	0.000624	0.00114	CcSEcCtD
Repaglinide—Constipation—Doxorubicin—ovarian cancer	0.000621	0.00113	CcSEcCtD
Repaglinide—Abdominal pain—Epirubicin—ovarian cancer	0.000621	0.00113	CcSEcCtD
Repaglinide—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000594	0.00108	CcSEcCtD
Repaglinide—Hypersensitivity—Epirubicin—ovarian cancer	0.000578	0.00106	CcSEcCtD
Repaglinide—Urticaria—Doxorubicin—ovarian cancer	0.000577	0.00105	CcSEcCtD
Repaglinide—Abdominal pain—Doxorubicin—ovarian cancer	0.000574	0.00105	CcSEcCtD
Repaglinide—Pruritus—Epirubicin—ovarian cancer	0.000555	0.00101	CcSEcCtD
Repaglinide—Diarrhoea—Epirubicin—ovarian cancer	0.000537	0.00098	CcSEcCtD
Repaglinide—Hypersensitivity—Doxorubicin—ovarian cancer	0.000535	0.000977	CcSEcCtD
Repaglinide—Pruritus—Doxorubicin—ovarian cancer	0.000514	0.000938	CcSEcCtD
Repaglinide—Vomiting—Epirubicin—ovarian cancer	0.000499	0.000911	CcSEcCtD
Repaglinide—Diarrhoea—Doxorubicin—ovarian cancer	0.000497	0.000907	CcSEcCtD
Repaglinide—Rash—Epirubicin—ovarian cancer	0.000495	0.000903	CcSEcCtD
Repaglinide—Dermatitis—Epirubicin—ovarian cancer	0.000495	0.000903	CcSEcCtD
Repaglinide—Headache—Epirubicin—ovarian cancer	0.000492	0.000898	CcSEcCtD
Repaglinide—Nausea—Epirubicin—ovarian cancer	0.000466	0.000851	CcSEcCtD
Repaglinide—Vomiting—Doxorubicin—ovarian cancer	0.000462	0.000843	CcSEcCtD
Repaglinide—Rash—Doxorubicin—ovarian cancer	0.000458	0.000836	CcSEcCtD
Repaglinide—Dermatitis—Doxorubicin—ovarian cancer	0.000458	0.000835	CcSEcCtD
Repaglinide—Headache—Doxorubicin—ovarian cancer	0.000455	0.00083	CcSEcCtD
Repaglinide—Nausea—Doxorubicin—ovarian cancer	0.000431	0.000787	CcSEcCtD
Repaglinide—KCNJ11—Metabolism—BRIP1—ovarian cancer	0.000292	0.00185	CbGpPWpGaD
Repaglinide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000287	0.00182	CbGpPWpGaD
Repaglinide—CYP2C8—Biological oxidations—CYP1B1—ovarian cancer	0.000284	0.0018	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—SPARC—ovarian cancer	0.000284	0.0018	CbGpPWpGaD
Repaglinide—CYP2C8—Metapathway biotransformation—CYP1B1—ovarian cancer	0.00028	0.00178	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—STAT3—ovarian cancer	0.000276	0.00175	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—RAD51C—ovarian cancer	0.000274	0.00174	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000265	0.00168	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000264	0.00167	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000256	0.00162	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—IL2—ovarian cancer	0.000254	0.00161	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CYTB—ovarian cancer	0.000247	0.00156	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000241	0.00153	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.00022	0.0014	CbGpPWpGaD
Repaglinide—ALB—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000219	0.00139	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000219	0.00139	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—PTEN—ovarian cancer	0.000218	0.00138	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000218	0.00138	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PPP1CC—ovarian cancer	0.000216	0.00137	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—BRIP1—ovarian cancer	0.000216	0.00137	CbGpPWpGaD
Repaglinide—ALB—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000212	0.00134	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000211	0.00134	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000209	0.00132	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—SOD1—ovarian cancer	0.000206	0.00131	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—YAP1—ovarian cancer	0.000202	0.00128	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—YAP1—ovarian cancer	0.000196	0.00124	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000195	0.00124	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYTB—ovarian cancer	0.000194	0.00123	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—IL6—ovarian cancer	0.000193	0.00122	CbGpPWpGaD
Repaglinide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	0.000191	0.00121	CbGpPWpGaD
Repaglinide—ABCC8—Neuronal System—MAPK1—ovarian cancer	0.00019	0.00121	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.00019	0.0012	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000188	0.00119	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—YAP1—ovarian cancer	0.000186	0.00118	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—VEGFA—ovarian cancer	0.000185	0.00117	CbGpPWpGaD
Repaglinide—KCNJ11—Neuronal System—MAPK1—ovarian cancer	0.000185	0.00117	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—IL6—ovarian cancer	0.000184	0.00116	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—ESR1—ovarian cancer	0.00018	0.00114	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—ovarian cancer	0.000176	0.00112	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—NME2—ovarian cancer	0.000173	0.0011	CbGpPWpGaD
Repaglinide—ALB—Metabolism—NME2—ovarian cancer	0.000172	0.00109	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MET—ovarian cancer	0.00017	0.00108	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PPP1CC—ovarian cancer	0.00017	0.00108	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—BRIP1—ovarian cancer	0.00017	0.00108	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000167	0.00106	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—IL6ST—ovarian cancer	0.000167	0.00106	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—FASN—ovarian cancer	0.000165	0.00104	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—TP53—ovarian cancer	0.000163	0.00103	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—PGR—ovarian cancer	0.000163	0.00103	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—SLC5A5—ovarian cancer	0.000162	0.00103	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—FASN—ovarian cancer	0.00016	0.00101	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000157	0.000997	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—SLC5A5—ovarian cancer	0.000157	0.000995	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—SLC2A1—ovarian cancer	0.000156	0.000991	CbGpPWpGaD
Repaglinide—ABCC8—Neuronal System—HRAS—ovarian cancer	0.000153	0.000968	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.000153	0.000967	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—SLC2A1—ovarian cancer	0.000152	0.000961	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—PARP1—ovarian cancer	0.000151	0.000958	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000151	0.000954	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CYP1B1—ovarian cancer	0.00015	0.00095	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—IL6—ovarian cancer	0.000149	0.000947	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—TP53—ovarian cancer	0.000149	0.000943	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000149	0.000943	CbGpPWpGaD
Repaglinide—KCNJ11—Neuronal System—HRAS—ovarian cancer	0.000148	0.000939	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000147	0.000932	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—SPARC—ovarian cancer	0.000146	0.000927	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000146	0.000927	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CYP1B1—ovarian cancer	0.000145	0.000922	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—YAP1—ovarian cancer	0.000145	0.000917	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000143	0.000908	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MMP2—ovarian cancer	0.000142	0.000901	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	0.000137	0.00087	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—IL6—ovarian cancer	0.000136	0.000863	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PPP2R1A—ovarian cancer	0.000133	0.000843	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PPP2R1A—ovarian cancer	0.000129	0.000817	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000126	0.000798	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—ERBB2—ovarian cancer	0.000125	0.000789	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000124	0.000785	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ABCB1—ovarian cancer	0.000123	0.000783	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—PPP2R1A—ovarian cancer	0.000123	0.000777	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—TYMS—ovarian cancer	0.000121	0.000769	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	0.000121	0.000765	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.00012	0.00076	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ABCB1—ovarian cancer	0.00012	0.000759	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000119	0.000756	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—IL6—ovarian cancer	0.000119	0.000752	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—FASN—ovarian cancer	0.000118	0.000748	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—TYMS—ovarian cancer	0.000118	0.000745	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—SLC5A5—ovarian cancer	0.000116	0.000736	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—YAP1—ovarian cancer	0.000114	0.000722	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000113	0.000715	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—SLC2A1—ovarian cancer	0.000112	0.00071	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYTB—ovarian cancer	0.000112	0.000708	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000111	0.000707	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYTB—ovarian cancer	0.000111	0.000704	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.00011	0.000696	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000109	0.000692	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—CTNNB1—ovarian cancer	0.000109	0.000691	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000109	0.000688	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000108	0.000682	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CYP1B1—ovarian cancer	0.000107	0.000681	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MMP9—ovarian cancer	0.000107	0.000677	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—SOD1—ovarian cancer	0.000106	0.000674	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PPP2R1A—ovarian cancer	0.000106	0.00067	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	0.000105	0.000667	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.92e-05	0.000628	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CAV1—ovarian cancer	9.77e-05	0.000619	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—BRIP1—ovarian cancer	9.76e-05	0.000619	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PPP1CC—ovarian cancer	9.76e-05	0.000619	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PPP1CC—ovarian cancer	9.71e-05	0.000615	CbGpPWpGaD
Repaglinide—ALB—Metabolism—BRIP1—ovarian cancer	9.71e-05	0.000615	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	9.66e-05	0.000613	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—VEGFA—ovarian cancer	9.59e-05	0.000608	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PPP2R1A—ovarian cancer	9.53e-05	0.000604	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—STAT3—ovarian cancer	9.5e-05	0.000602	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	9.48e-05	0.000601	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CAV1—ovarian cancer	9.48e-05	0.000601	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—NRAS—ovarian cancer	9.47e-05	0.000601	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—MYC—ovarian cancer	9.38e-05	0.000594	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NME2—ovarian cancer	9.3e-05	0.00059	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—FASN—ovarian cancer	9.29e-05	0.000589	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—SLC5A5—ovarian cancer	9.14e-05	0.000579	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MAPK3—ovarian cancer	9.07e-05	0.000575	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CG—ovarian cancer	8.9e-05	0.000564	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ABCB1—ovarian cancer	8.85e-05	0.000561	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—SLC2A1—ovarian cancer	8.83e-05	0.000559	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—TYMS—ovarian cancer	8.69e-05	0.000551	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—ESR1—ovarian cancer	8.68e-05	0.00055	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.64e-05	0.000548	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MAPK1—ovarian cancer	8.63e-05	0.000547	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—EGFR—ovarian cancer	8.63e-05	0.000547	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CG—ovarian cancer	8.63e-05	0.000547	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	8.5e-05	0.000539	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYP1B1—ovarian cancer	8.46e-05	0.000536	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	8.21e-05	0.000521	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—KRAS—ovarian cancer	8.15e-05	0.000517	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CD—ovarian cancer	7.82e-05	0.000496	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—CAV1—ovarian cancer	7.77e-05	0.000493	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	7.77e-05	0.000492	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CD—ovarian cancer	7.59e-05	0.000481	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PPP2R1A—ovarian cancer	7.5e-05	0.000476	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.47e-05	0.000473	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	7.39e-05	0.000469	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.12e-05	0.000451	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CG—ovarian cancer	7.08e-05	0.000449	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.07e-05	0.000448	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CAV1—ovarian cancer	7e-05	0.000444	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ABCB1—ovarian cancer	6.97e-05	0.000442	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—HRAS—ovarian cancer	6.93e-05	0.000439	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—TYMS—ovarian cancer	6.84e-05	0.000434	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CB—ovarian cancer	6.82e-05	0.000432	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.69e-05	0.000424	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—IL6—ovarian cancer	6.63e-05	0.00042	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CB—ovarian cancer	6.61e-05	0.000419	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—YAP1—ovarian cancer	6.55e-05	0.000415	CbGpPWpGaD
Repaglinide—ALB—Metabolism—YAP1—ovarian cancer	6.51e-05	0.000413	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.48e-05	0.000411	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.44e-05	0.000408	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	6.41e-05	0.000407	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CG—ovarian cancer	6.38e-05	0.000404	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CD—ovarian cancer	6.22e-05	0.000394	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—AKT1—ovarian cancer	6.12e-05	0.000388	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYTB—ovarian cancer	6e-05	0.00038	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PTEN—ovarian cancer	5.89e-05	0.000374	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTEN—ovarian cancer	5.71e-05	0.000362	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.7e-05	0.000361	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.67e-05	0.000359	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CD—ovarian cancer	5.61e-05	0.000355	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CAV1—ovarian cancer	5.51e-05	0.00035	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CB—ovarian cancer	5.42e-05	0.000344	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—FASN—ovarian cancer	5.34e-05	0.000338	CbGpPWpGaD
Repaglinide—ALB—Metabolism—FASN—ovarian cancer	5.31e-05	0.000336	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.27e-05	0.000334	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SLC5A5—ovarian cancer	5.25e-05	0.000333	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPP1CC—ovarian cancer	5.24e-05	0.000332	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—BRIP1—ovarian cancer	5.24e-05	0.000332	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	5.24e-05	0.000332	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SLC5A5—ovarian cancer	5.22e-05	0.000331	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SLC2A1—ovarian cancer	5.07e-05	0.000321	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SLC2A1—ovarian cancer	5.04e-05	0.00032	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	5.02e-05	0.000318	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IL2—ovarian cancer	4.98e-05	0.000316	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.97e-05	0.000315	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.94e-05	0.000313	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CB—ovarian cancer	4.89e-05	0.00031	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP1B1—ovarian cancer	4.86e-05	0.000308	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP1B1—ovarian cancer	4.83e-05	0.000306	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—MAPK3—ovarian cancer	4.64e-05	0.000294	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—MYC—ovarian cancer	4.51e-05	0.000286	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	4.42e-05	0.00028	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	4.31e-05	0.000273	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.29e-05	0.000272	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PPP2R1A—ovarian cancer	4.29e-05	0.000272	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.27e-05	0.00027	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—VEGFA—ovarian cancer	4.23e-05	0.000268	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTEN—ovarian cancer	4.22e-05	0.000268	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—NRAS—ovarian cancer	4.18e-05	0.000265	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CA—ovarian cancer	4.16e-05	0.000264	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CA—ovarian cancer	4.03e-05	0.000256	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—MAPK3—ovarian cancer	4e-05	0.000254	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ABCB1—ovarian cancer	4e-05	0.000254	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ABCB1—ovarian cancer	3.98e-05	0.000252	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—TYMS—ovarian cancer	3.93e-05	0.000249	CbGpPWpGaD
Repaglinide—ALB—Metabolism—TYMS—ovarian cancer	3.91e-05	0.000248	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	3.85e-05	0.000244	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—MAPK1—ovarian cancer	3.81e-05	0.000242	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—KRAS—ovarian cancer	3.6e-05	0.000228	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—YAP1—ovarian cancer	3.52e-05	0.000223	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—AKT1—ovarian cancer	3.4e-05	0.000215	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTEN—ovarian cancer	3.33e-05	0.000211	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CA—ovarian cancer	3.31e-05	0.00021	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—AKT1—ovarian cancer	3.29e-05	0.000209	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TP53—ovarian cancer	3.2e-05	0.000203	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CAV1—ovarian cancer	3.17e-05	0.000201	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CAV1—ovarian cancer	3.15e-05	0.0002	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—AKT1—ovarian cancer	3.13e-05	0.000198	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—HRAS—ovarian cancer	3.06e-05	0.000194	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.03e-05	0.000192	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.01e-05	0.000191	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CA—ovarian cancer	2.98e-05	0.000189	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CG—ovarian cancer	2.89e-05	0.000183	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CG—ovarian cancer	2.87e-05	0.000182	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—FASN—ovarian cancer	2.87e-05	0.000182	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SLC5A5—ovarian cancer	2.82e-05	0.000179	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SLC2A1—ovarian cancer	2.72e-05	0.000173	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—AKT1—ovarian cancer	2.7e-05	0.000171	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.61e-05	0.000165	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CD—ovarian cancer	2.54e-05	0.000161	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CD—ovarian cancer	2.52e-05	0.00016	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—AKT1—ovarian cancer	2.43e-05	0.000154	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	2.35e-05	0.000149	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.31e-05	0.000147	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CB—ovarian cancer	2.21e-05	0.00014	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CB—ovarian cancer	2.2e-05	0.000139	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.15e-05	0.000136	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—TYMS—ovarian cancer	2.11e-05	0.000134	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AKT1—ovarian cancer	1.92e-05	0.000121	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTEN—ovarian cancer	1.91e-05	0.000121	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTEN—ovarian cancer	1.9e-05	0.00012	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CAV1—ovarian cancer	1.7e-05	0.000108	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.55e-05	9.82e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.36e-05	8.63e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CA—ovarian cancer	1.35e-05	8.55e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CA—ovarian cancer	1.34e-05	8.5e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.19e-05	7.52e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AKT1—ovarian cancer	1.1e-05	6.98e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AKT1—ovarian cancer	1.1e-05	6.94e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTEN—ovarian cancer	1.03e-05	6.5e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CA—ovarian cancer	7.24e-06	4.59e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AKT1—ovarian cancer	5.91e-06	3.75e-05	CbGpPWpGaD
